← Leaderboards
Asim B Abdel-Mageed
Tulane University Of Louisiana
$4,774,466
Attributed
$4,774,466
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $999.9K · FY2011–17$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$4,774,466 · 4
By mechanism
UH3$1,999,831 · 1
U01$1,388,637 · 1
UH2$1,312,006 · 1
R03$73,992 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Timothy G Hammond$1,009,230
- William McKinnon$49,515
- Walter L Murfee$2,965,430
- Ana M Comaru-Schally$12,594
Others in their field
Top investigators on “Cancer Patient”
- David Heimbrook · Leidos Biomedical Research, Inc.$436,176,488
- Larry Arthur$370,429,903
- Norman Wolmark · Nsabp Foundation, Inc.$324,028,859
- Gregory H Reaman · National Childhood Cancer Foundation$270,366,096
- Leonard Freedman · Leidos Biomedical Research, Inc.$268,085,841
- Richard A Gibbs · Baylor College Of Medicine$240,560,484
Research focus
Cancer PatientMediatingRecruitment ActivityBaseTumor GrowthTumor ProgressionLeadIn VivoNeoplasm MetastasisObesityTumor-DerivedProstatic NeoplasmsTumorStem CellsAdipose TissueCellsInnovationIn VitroResearch StudyNeoplastic CellPreventiveConditioned Culture MediaPc3 Cell LineAndrogen Receptor
Grant awards (11)
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni$999,911
UH3 · FY2017 · TR · contact PI
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni$999,920
UH3 · FY2016 · TR · contact PI
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni$386,389
UH2 · FY2015 · TR · contact PI
Estrogen-ERbeta Axis In Disparity of Prostate Cancer$279,828
U01 · FY2015 · CA · contact PI
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni$425,691
UH2 · FY2014 · TR · contact PI
Estrogen-ERbeta Axis In Disparity of Prostate Cancer$271,258
U01 · FY2014 · CA · contact PI
Targeting Tumor-Derived exRNA-Containing Microvesicles by High Throughput Screeni$499,926
UH2 · FY2013 · TR · contact PI
Estrogen-ERbeta Axis In Disparity of Prostate Cancer$228,392
U01 · FY2013 · CA · contact PI
Estrogen-ERbeta Axis In Disparity of Prostate Cancer$299,290
U01 · FY2012 · CA · contact PI
Estrogen-ERbeta Axis In Disparity of Prostate Cancer$309,869
U01 · FY2011 · CA · contact PI
METALLOTHIONEIN AND PROSTATE TUMORIGENESIS$73,992
R03 · FY2000 · DK